LOPERAMIDE HYDROCHLORIDE

LOPERAMIDE HYDROCHLORIDE was reported 45181 times

LOPERAMIDE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOTAL LUNG CAPACITY INCREASED 121 0.4449
1 BLOOD MERCURY ABNORMAL 41 0.4184
2 VAGINAL FLATULENCE 112 0.3696
3 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 102 0.1950
4 PRESBYACUSIS 56 0.1818
5 GASTROINTESTINAL PROCEDURAL COMPLICATION 38 0.1418
6 GASTROINTESTINAL STOMA OUTPUT INCREASED 50 0.1066
7 FEMALE GENITAL TRACT FISTULA 129 0.0755
8 PRODUCT BLISTER PACKAGING ISSUE 77 0.0740
9 PLEURAL THICKENING 44 0.0643
10 PRODUCT PACKAGE ASSOCIATED INJURY 143 0.0641
11 PLEURAL FIBROSIS 63 0.0618
12 BLOOD MAGNESIUM INCREASED 51 0.0565
13 PRODUCT PACKAGING DIFFICULT TO OPEN 140 0.0536
14 JAUNDICE CHOLESTATIC 180 0.0509
15 ANTICHOLINERGIC SYNDROME 81 0.0508
16 HYPOMANIA 184 0.0500
17 BRONCHIAL WALL THICKENING 35 0.0487
18 BACTERIAL DISEASE CARRIER 35 0.0480
19 PROCTITIS 134 0.0478
20 CHRONIC SINUSITIS 170 0.0452
21 RADICULOPATHY 117 0.0444
22 GASTROINTESTINAL STOMA COMPLICATION 62 0.0394
23 PRODUCT DIFFICULT TO SWALLOW 38 0.0374
24 POUCHITIS 32 0.0372
25 PRODUCT PACKAGING ISSUE 334 0.0351
26 STOMA COMPLICATION 35 0.0344
27 BRONCHIAL SECRETION RETENTION 40 0.0314
28 VASCULAR DEVICE INFECTION 137 0.0302
29 RHINITIS ALLERGIC 132 0.0296
30 LOW DENSITY LIPOPROTEIN DECREASED 41 0.0289
31 TUMOUR PAIN 38 0.0288
32 INFREQUENT BOWEL MOVEMENTS 71 0.0285
33 INCORRECT PRODUCT ADMINISTRATION DURATION 578 0.0267
34 MACULAR DEGENERATION 317 0.0265
35 THERAPEUTIC REACTION TIME DECREASED 75 0.0257
36 BLOOD PRESSURE DIASTOLIC ABNORMAL 64 0.0251
37 COLITIS MICROSCOPIC 114 0.0240
38 SARCOIDOSIS 110 0.0231
39 BLOOD PRESSURE SYSTOLIC ABNORMAL 57 0.0230
40 OSTEOSCLEROSIS 35 0.0222
41 SCHIZOPHRENIA 266 0.0219
42 NASAL POLYPS 107 0.0217
43 EPIGASTRIC DISCOMFORT 78 0.0199
44 CATHETER SITE ERYTHEMA 42 0.0196
45 TORSADE DE POINTES 152 0.0194
46 FREQUENT BOWEL MOVEMENTS 518 0.0192
47 SMALL INTESTINAL OBSTRUCTION 234 0.0190
48 DEAFNESS NEUROSENSORY 62 0.0188
49 EXPIRED PRODUCT ADMINISTERED 623 0.0187
50 BRONCHIECTASIS 124 0.0184
51 INFUSION SITE DISCHARGE 32 0.0182
52 ANAL INCONTINENCE 162 0.0180
53 DEFAECATION URGENCY 123 0.0175
54 ABSCESS INTESTINAL 37 0.0172
55 DEVICE INFUSION ISSUE 42 0.0169
56 BLOOD MAGNESIUM DECREASED 146 0.0169
57 PRODUCT SIZE ISSUE 90 0.0167
58 PNEUMONIA ASPIRATION 414 0.0166
59 HEPATIC NEOPLASM 54 0.0165
60 FAECES SOFT 120 0.0165
61 BLOOD PRESSURE DIASTOLIC DECREASED 121 0.0164
62 GASTROINTESTINAL SOUNDS ABNORMAL 81 0.0163
63 OXYGEN CONSUMPTION INCREASED 39 0.0163
64 CARDIAC MURMUR 136 0.0157
65 ANAL FISSURE 83 0.0155
66 GASTROINTESTINAL OBSTRUCTION 37 0.0154
67 HYPERPARATHYROIDISM SECONDARY 38 0.0152
68 DEVICE RELATED SEPSIS 30 0.0149
69 ABNORMAL FAECES 121 0.0148
70 INFUSION SITE INFECTION 34 0.0146
71 APPETITE DISORDER 97 0.0146
72 INFUSION SITE HAEMORRHAGE 48 0.0146
73 BLOOD PRESSURE SYSTOLIC INCREASED 283 0.0145
74 HYPOMAGNESAEMIA 202 0.0145
75 LARGE INTESTINAL ULCER 39 0.0144
76 FAECES DISCOLOURED 308 0.0142
77 FAECES HARD 55 0.0141
78 ORAL CANDIDIASIS 185 0.0140
79 DIARRHOEA 9029 0.0140
80 RALES 81 0.0139
81 FAECALOMA 76 0.0139
82 INTENTIONAL PRODUCT USE ISSUE 1201 0.0137
83 ENTEROCOLITIS 79 0.0137
84 COLITIS 516 0.0136
85 BLOOD PRESSURE DIASTOLIC INCREASED 62 0.0134
86 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 68 0.0133
87 FAECAL CALPROTECTIN INCREASED 42 0.0132
88 MUCOUS STOOLS 65 0.0131
89 CROHN'S DISEASE 88 0.0128
90 ENTERITIS 82 0.0128
91 BOWEL MOVEMENT IRREGULARITY 98 0.0128
92 OBSTRUCTION 51 0.0128
93 PROCTALGIA 81 0.0126
94 FLATULENCE 711 0.0125
95 THERAPEUTIC RESPONSE DELAYED 34 0.0121
96 LARGE INTESTINE POLYP 84 0.0121
97 CANCER PAIN 31 0.0121
98 NEUTROPHIL COUNT ABNORMAL 34 0.0120
99 PARAESTHESIA ORAL 173 0.0120
100 IMMUNE-MEDIATED ENTEROCOLITIS 44 0.0120
101 DEHYDRATION 1595 0.0119
102 FAILURE TO THRIVE 62 0.0119
103 EXPOSURE TO TOXIC AGENT 38 0.0119
104 VAGINAL DISCHARGE 120 0.0118
105 RHINOVIRUS INFECTION 46 0.0118
106 GASTROINTESTINAL MOTILITY DISORDER 63 0.0118
107 CONSTIPATION 2541 0.0116
108 CHOLELITHIASIS 381 0.0116
109 ABDOMINAL ADHESIONS 36 0.0114
110 BLOOD POTASSIUM DECREASED 341 0.0113
111 HYPOKALAEMIA 517 0.0112
112 PRODUCT USE COMPLAINT 176 0.0112
113 ANAL FISTULA 59 0.0110
114 NEPHROGENIC ANAEMIA 51 0.0110
115 INTESTINAL OBSTRUCTION 408 0.0108
116 SPINAL CORD COMPRESSION 42 0.0108
117 HAEMOGLOBIN INCREASED 49 0.0107
118 SEASONAL ALLERGY 152 0.0107
119 INFUSION SITE PAIN 138 0.0107
120 INFUSION SITE ERYTHEMA 90 0.0107
121 FISTULA 120 0.0107
122 MALNUTRITION 119 0.0106
123 HYPOVOLAEMIA 62 0.0106
124 BLOOD BILIRUBIN INCREASED 285 0.0105
125 INFUSION SITE SWELLING 66 0.0105
126 CLOSTRIDIUM DIFFICILE COLITIS 111 0.0105
127 ONYCHOCLASIS 72 0.0105
128 HAEMORRHOIDS 204 0.0104
129 HAEMORRHAGIC DIATHESIS 37 0.0104
130 IDIOPATHIC PULMONARY FIBROSIS 41 0.0104
131 TASTE DISORDER 209 0.0103
132 ARTERIOSCLEROSIS CORONARY ARTERY 68 0.0103
133 HEPATIC LESION 44 0.0102
134 LUNG NEOPLASM 43 0.0101
135 GASTROINTESTINAL PAIN 110 0.0100
136 VENTRICULAR TACHYCARDIA 165 0.0100
137 GASTROOESOPHAGEAL REFLUX DISEASE 804 0.0100
138 HAEMATOCHEZIA 551 0.0100
139 HYPERVOLAEMIA 49 0.0099
140 HYPOPHOSPHATAEMIA 73 0.0099
141 PRODUCT LABEL ISSUE 67 0.0099
142 ORAL PAIN 221 0.0099
143 FOREIGN BODY IN THROAT 31 0.0098
144 ANORECTAL DISCOMFORT 52 0.0098
145 PNEUMONIA VIRAL 31 0.0097
146 MUSCULOSKELETAL CHEST PAIN 150 0.0097
147 WEIGHT FLUCTUATION 101 0.0096
148 ELECTROLYTE IMBALANCE 112 0.0096
149 BLOOD IRON DECREASED 114 0.0096
150 THERAPEUTIC PRODUCT EFFECT VARIABLE 37 0.0095
151 COMA 451 0.0095
152 VENTRICULAR ARRHYTHMIA 34 0.0093
153 CLOSTRIDIUM DIFFICILE INFECTION 201 0.0092
154 DERMATITIS ACNEIFORM 56 0.0092
155 RETCHING 196 0.0092
156 TONGUE DISCOMFORT 39 0.0092
157 HEPATOTOXICITY 202 0.0091
158 BODY TEMPERATURE DECREASED 89 0.0090
159 PROTEIN TOTAL DECREASED 34 0.0090
160 INTESTINAL STENOSIS 38 0.0090
161 HAEMATOCRIT DECREASED 176 0.0089
162 RECTAL HAEMORRHAGE 381 0.0089
163 TENDERNESS 92 0.0088
164 ILEUS 109 0.0088
165 ILEUS PARALYTIC 39 0.0087
166 DIARRHOEA HAEMORRHAGIC 81 0.0087
167 BLOOD CALCIUM DECREASED 97 0.0086
168 BONE LESION 31 0.0086
169 HAEMORRHOIDAL HAEMORRHAGE 41 0.0084
170 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 32 0.0084
171 ABDOMINAL ABSCESS 37 0.0084
172 DECUBITUS ULCER 68 0.0083
173 YELLOW SKIN 39 0.0083
174 COLITIS ULCERATIVE 370 0.0083
175 RED BLOOD CELL COUNT DECREASED 236 0.0082
176 FOREIGN BODY 33 0.0082
177 INCORRECT DRUG ADMINISTRATION DURATION 231 0.0082
178 IRRITABLE BOWEL SYNDROME 176 0.0082
179 ANAL ABSCESS 44 0.0082
180 PAIN IN JAW 230 0.0081
181 GASTROENTERITIS 118 0.0081
182 STOMATITIS 490 0.0081
183 ATELECTASIS 78 0.0081
184 DYSPNOEA EXERTIONAL 304 0.0081
185 CYST 100 0.0080
186 OSTEOPENIA 122 0.0080
187 ARTHRITIS INFECTIVE 37 0.0080
188 HYPOALBUMINAEMIA 62 0.0080
189 PARONYCHIA 35 0.0080
190 DECREASED APPETITE 1847 0.0079
191 ABDOMINAL PAIN 1846 0.0079
192 MUCOSAL INFLAMMATION 207 0.0079
193 SKIN WARM 46 0.0079
194 DRUG LEVEL ABOVE THERAPEUTIC 36 0.0079
195 PRODUCTIVE COUGH 373 0.0078
196 DERMATITIS CONTACT 89 0.0078
197 HAIR COLOUR CHANGES 96 0.0077
198 RIGHT VENTRICULAR FAILURE 54 0.0077
199 IRON DEFICIENCY ANAEMIA 71 0.0077
200 HYPOCALCAEMIA 145 0.0077
201 ELECTROCARDIOGRAM QT PROLONGED 275 0.0076
202 ABDOMINAL DISTENSION 796 0.0076
203 HYDRONEPHROSIS 57 0.0076
204 WEIGHT DECREASED 2125 0.0076
205 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 176 0.0075
206 DYSPEPSIA 741 0.0075
207 INTESTINAL PERFORATION 84 0.0075
208 RED CELL DISTRIBUTION WIDTH INCREASED 31 0.0075
209 INTESTINAL ISCHAEMIA 41 0.0074
210 BLOOD SODIUM DECREASED 140 0.0074
211 DIZZINESS POSTURAL 72 0.0074
212 CHOLECYSTITIS ACUTE 42 0.0074
213 GASTROINTESTINAL INFECTION 66 0.0074
214 PROCEDURAL PAIN 204 0.0073
215 DIVERTICULUM 52 0.0073
216 DYSPHORIA 37 0.0073
217 FAECAL INCONTINENCE 35 0.0073
218 ABSCESS LIMB 31 0.0073
219 ABDOMINAL HERNIA 33 0.0072
220 BLOOD POTASSIUM INCREASED 117 0.0072
221 LARGE INTESTINE PERFORATION 50 0.0072
222 BLOOD ALBUMIN DECREASED 57 0.0072
223 POLYP 47 0.0072
224 POOR VENOUS ACCESS 74 0.0071
225 LOCALISED OEDEMA 33 0.0071
226 ORAL DISCOMFORT 99 0.0071
227 DIVERTICULUM INTESTINAL 31 0.0071
228 SPUTUM DISCOLOURED 67 0.0071
229 MUSCLE STRAIN 61 0.0070
230 NEOPLASM 81 0.0070
231 PURULENT DISCHARGE 30 0.0070
232 TOXIC EPIDERMAL NECROLYSIS 106 0.0070
233 ATRIOVENTRICULAR BLOCK FIRST DEGREE 30 0.0069
234 CHAPPED LIPS 30 0.0069
235 NON-SMALL CELL LUNG CANCER 33 0.0069
236 MULTIPLE ALLERGIES 54 0.0069
237 HYPERKERATOSIS 38 0.0069
238 APHTHOUS ULCER 53 0.0068
239 OBSTRUCTIVE AIRWAYS DISORDER 76 0.0068
240 RESPIRATION ABNORMAL 47 0.0068
241 ASCITES 199 0.0068
242 PNEUMONITIS 184 0.0068
243 COLECTOMY 38 0.0067
244 UROSEPSIS 62 0.0067
245 BLOOD CREATININE INCREASED 438 0.0067
246 DRUG LEVEL BELOW THERAPEUTIC 37 0.0067
247 FLANK PAIN 62 0.0066
248 FLUID INTAKE REDUCED 33 0.0066
249 FEBRILE NEUTROPENIA 437 0.0066
250 THERAPEUTIC PRODUCT EFFECT DELAYED 30 0.0066
251 PSYCHOTIC DISORDER 194 0.0066
252 WHEEZING 387 0.0065
253 PERIPHERAL SENSORY NEUROPATHY 38 0.0065
254 PANCREATIC DISORDER 32 0.0065
255 FOOD POISONING 34 0.0063
256 DEVICE RELATED INFECTION 97 0.0063
257 BREATH SOUNDS ABNORMAL 31 0.0063
258 LIPASE INCREASED 48 0.0063
259 OESOPHAGITIS 67 0.0061
260 PLEURAL EFFUSION 370 0.0061
261 LYMPHOEDEMA 42 0.0061
262 INCONTINENCE 64 0.0060
263 CARDIOTOXICITY 54 0.0060
264 SPINAL OSTEOARTHRITIS 53 0.0060
265 OEDEMA PERIPHERAL 732 0.0060
266 GASTROINTESTINAL INFLAMMATION 47 0.0060
267 VOMITING 2818 0.0060
268 ANAEMIA 1140 0.0060
269 CHOLANGITIS 37 0.0060
270 SENSITIVE SKIN 44 0.0060
271 INCORRECT DOSE ADMINISTERED 1360 0.0060
272 DUODENAL ULCER 42 0.0059
273 COLITIS ISCHAEMIC 40 0.0059
274 ABDOMINAL PAIN UPPER 1218 0.0059
275 BLOOD UREA INCREASED 99 0.0059
276 PRODUCT TASTE ABNORMAL 80 0.0059
277 METASTASES TO LUNG 68 0.0059
278 SKIN FISSURES 115 0.0059
279 OSTEOARTHRITIS 249 0.0059
280 GAMMA-GLUTAMYLTRANSFERASE INCREASED 130 0.0059
281 LIGAMENT SPRAIN 58 0.0059
282 SUPRAVENTRICULAR TACHYCARDIA 56 0.0058
283 FEEDING DISORDER 118 0.0058
284 SPLENOMEGALY 68 0.0058
285 DRUG LEVEL DECREASED 59 0.0058
286 MALABSORPTION 30 0.0057
287 NAIL DISORDER 50 0.0057
288 ABDOMINAL DISCOMFORT 958 0.0057
289 PULMONARY THROMBOSIS 62 0.0057
290 FULL BLOOD COUNT ABNORMAL 60 0.0057
291 ATRIAL FLUTTER 45 0.0056
292 FEELING COLD 157 0.0056
293 CHOKING SENSATION 31 0.0056
294 SKIN LESION 154 0.0056
295 EAR PAIN 109 0.0056
296 NASAL DRYNESS 35 0.0056
297 GASTROINTESTINAL DISORDER 495 0.0055
298 NAUSEA 4357 0.0055
299 HYPONATRAEMIA 310 0.0055
300 HAEMOGLOBIN DECREASED 565 0.0055
301 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 391 0.0055
302 NEUTROPHIL COUNT DECREASED 224 0.0055
303 VENTRICULAR FIBRILLATION 61 0.0055
304 HIATUS HERNIA 71 0.0055
305 ERUCTATION 106 0.0055
306 BACTERAEMIA 65 0.0055
307 PULMONARY HYPERTENSION 114 0.0055
308 INTENTIONAL PRODUCT MISUSE 479 0.0055
309 OSTEOMYELITIS 99 0.0055
310 RENAL FAILURE CHRONIC 42 0.0055
311 FRUSTRATION TOLERANCE DECREASED 44 0.0054
312 PLATELET COUNT DECREASED 579 0.0054
313 NIGHT SWEATS 175 0.0054
314 GASTROENTERITIS VIRAL 98 0.0054
315 BLOOD PRESSURE FLUCTUATION 130 0.0054
316 VITAMIN D DECREASED 46 0.0054
317 BACTERIAL INFECTION 100 0.0054
318 FULL BLOOD COUNT DECREASED 108 0.0054
319 EJECTION FRACTION DECREASED 83 0.0053
320 RHINORRHOEA 345 0.0053
321 DYSGEUSIA 396 0.0053
322 INCREASED TENDENCY TO BRUISE 49 0.0053
323 LUNG INFILTRATION 47 0.0053
324 OXYGEN SATURATION DECREASED 299 0.0053
325 HYPOPHAGIA 136 0.0053
326 INFLAMMATORY BOWEL DISEASE 52 0.0053
327 DIVERTICULITIS 147 0.0053
328 BRAIN INJURY 53 0.0053
329 HYPOXIA 186 0.0053
330 LOWER GASTROINTESTINAL HAEMORRHAGE 39 0.0053
331 FLUID RETENTION 268 0.0053
332 URINE OUTPUT DECREASED 46 0.0053
333 ABDOMINAL PAIN LOWER 133 0.0053
334 EPISTAXIS 393 0.0052
335 AGEUSIA 131 0.0052
336 ACUTE RESPIRATORY FAILURE 101 0.0052
337 HEART RATE DECREASED 184 0.0052
338 METASTASES TO LIVER 92 0.0052
339 ESCHERICHIA INFECTION 43 0.0052
340 GRIP STRENGTH DECREASED 46 0.0052
341 HEPATIC ENZYME INCREASED 356 0.0052
342 SKIN ATROPHY 30 0.0052
343 RENAL PAIN 55 0.0052
344 URINARY TRACT INFECTION 882 0.0052
345 WHITE BLOOD CELL COUNT DECREASED 557 0.0051
346 GASTRITIS 135 0.0051
347 BLOOD ALKALINE PHOSPHATASE INCREASED 127 0.0051
348 BRAIN FOG 80 0.0051
349 PRODUCT ADMINISTRATION INTERRUPTED 40 0.0051
350 CHROMATURIA 115 0.0051
351 SEPSIS 566 0.0051
352 FATIGUE 3949 0.0051
353 PNEUMONIA 1641 0.0051
354 DYSPHAGIA 481 0.0051
355 HOSPICE CARE 50 0.0051
356 HAIR GROWTH ABNORMAL 35 0.0051
357 THERAPY NON-RESPONDER 227 0.0050
358 MOUTH HAEMORRHAGE 37 0.0050
359 ANOREXIA 65 0.0050
360 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 262 0.0050
361 DRY THROAT 51 0.0050
362 PROTHROMBIN TIME PROLONGED 30 0.0050
363 HICCUPS 41 0.0050
364 BLOOD TEST ABNORMAL 70 0.0050
365 PNEUMOTHORAX 79 0.0050
366 CHOKING 97 0.0050
367 DYSURIA 183 0.0050
368 SQUAMOUS CELL CARCINOMA OF SKIN 30 0.0050
369 SKIN LACERATION 54 0.0050
370 ASTHENIA 1867 0.0050
371 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
372 OROPHARYNGEAL PAIN 456 0.0049
373 NEUROPATHY PERIPHERAL 468 0.0049
374 LEUKOCYTOSIS 89 0.0049
375 ORAL DISORDER 36 0.0049
376 PRESYNCOPE 119 0.0049
377 PANCREATITIS ACUTE 110 0.0049
378 PRODUCT DISTRIBUTION ISSUE 45 0.0048
379 DYSPHONIA 283 0.0048
380 WRIST FRACTURE 58 0.0048
381 COUGH 1356 0.0048
382 GINGIVAL BLEEDING 66 0.0048
383 PULMONARY ARTERIAL HYPERTENSION 70 0.0048
384 PHARYNGITIS STREPTOCOCCAL 52 0.0048
385 CHOLECYSTITIS 57 0.0048
386 TRANSFUSION 50 0.0048
387 RIB FRACTURE 98 0.0048
388 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 338 0.0047
389 PERIPHERAL SWELLING 731 0.0047
390 OEDEMA 257 0.0047
391 C-REACTIVE PROTEIN INCREASED 172 0.0047
392 SKIN INFECTION 53 0.0047
393 HEPATIC STEATOSIS 88 0.0047
394 BLOOD PRESSURE INCREASED 722 0.0047
395 PERICARDIAL EFFUSION 109 0.0047
396 EXOSTOSIS 43 0.0047
397 ADRENAL INSUFFICIENCY 57 0.0047
398 POOR QUALITY SLEEP 101 0.0047
399 SECOND PRIMARY MALIGNANCY 39 0.0047
400 DECREASED IMMUNE RESPONSIVENESS 46 0.0047
401 PNEUMONIA BACTERIAL 43 0.0047
402 THERAPY PARTIAL RESPONDER 73 0.0047
403 RENAL FAILURE ACUTE 198 0.0047
404 SEPTIC SHOCK 203 0.0047
405 TRICUSPID VALVE INCOMPETENCE 37 0.0047
406 LIMB DISCOMFORT 144 0.0046
407 ACUTE KIDNEY INJURY 712 0.0046
408 EATING DISORDER 99 0.0046
409 LYMPHOCYTE COUNT DECREASED 82 0.0046
410 ABSCESS 74 0.0046
411 MALIGNANT NEOPLASM PROGRESSION 474 0.0046
412 TOOTH INFECTION 61 0.0046
413 CELLULITIS 233 0.0046
414 PELVIC FRACTURE 36 0.0046
415 THROAT IRRITATION 207 0.0046
416 INFUSION RELATED REACTION 305 0.0046
417 POSTOPERATIVE WOUND INFECTION 31 0.0046
418 SQUAMOUS CELL CARCINOMA 43 0.0046
419 TOXIC SKIN ERUPTION 46 0.0046
420 PYREXIA 1574 0.0045
421 ABNORMAL LOSS OF WEIGHT 31 0.0045
422 FOOD ALLERGY 35 0.0045
423 NOCTURIA 55 0.0045
424 DRUG ABUSE 376 0.0045
425 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 811 0.0045
426 SYNCOPE 450 0.0045
427 METASTASES TO CENTRAL NERVOUS SYSTEM 58 0.0045
428 SKIN ULCER 116 0.0045
429 GASTRIC ULCER 85 0.0045
430 CARDIOMEGALY 55 0.0045
431 BREAST CANCER METASTATIC 48 0.0045
432 GOUT 80 0.0045
433 TOOTH DISORDER 99 0.0044
434 METASTASES TO LYMPH NODES 30 0.0044
435 GALLBLADDER DISORDER 79 0.0044
436 DRY MOUTH 359 0.0044
437 IMMUNOSUPPRESSION 39 0.0044
438 BLISTER 247 0.0044
439 NASAL CONGESTION 258 0.0044
440 NEPHROLITHIASIS 201 0.0044
441 SOMNOLENCE 882 0.0044
442 HYPOTENSION 878 0.0044
443 ATRIAL FIBRILLATION 425 0.0044
444 INTENTIONAL SELF-INJURY 88 0.0044
445 TROPONIN INCREASED 33 0.0043
446 EMBOLISM 36 0.0043
447 HYPOTHYROIDISM 138 0.0043
448 ACIDOSIS 33 0.0043
449 INTERVERTEBRAL DISC PROTRUSION 94 0.0043
450 LYMPHADENOPATHY 152 0.0043
451 MASS 60 0.0043
452 DRY EYE 214 0.0043
453 END STAGE RENAL DISEASE 78 0.0043
454 NEUTROPENIA 581 0.0043
455 HYPERBILIRUBINAEMIA 44 0.0042
456 MUSCULOSKELETAL DISCOMFORT 73 0.0042
457 BASAL CELL CARCINOMA 66 0.0042
458 COLON CANCER 63 0.0042
459 BLOOD PRESSURE ABNORMAL 84 0.0042
460 CYSTITIS 134 0.0042
461 UNDERDOSE 307 0.0042
462 CHILLS 493 0.0042
463 PANCYTOPENIA 235 0.0042
464 WOUND INFECTION 46 0.0042
465 ASPIRATION 46 0.0042
466 HERNIA 81 0.0042
467 MUSCLE SPASMS 767 0.0042
468 ASPARTATE AMINOTRANSFERASE INCREASED 222 0.0042
469 RENAL CYST 33 0.0042
470 SINUS CONGESTION 56 0.0041
471 WHITE BLOOD CELL COUNT INCREASED 159 0.0041
472 SINUS DISORDER 82 0.0041
473 LABORATORY TEST ABNORMAL 122 0.0041
474 MOUTH ULCERATION 87 0.0041
475 UPPER-AIRWAY COUGH SYNDROME 34 0.0041
476 TOOTH ABSCESS 42 0.0041
477 HYPERGLYCAEMIA 150 0.0041
478 BRONCHITIS 304 0.0041
479 BLOOD COUNT ABNORMAL 62 0.0041
480 THIRST 73 0.0041
481 PSEUDOMONAS INFECTION 35 0.0041
482 ELECTROCARDIOGRAM ABNORMAL 32 0.0041
483 URINARY RETENTION 136 0.0041
484 POST PROCEDURAL INFECTION 33 0.0041
485 THERAPEUTIC RESPONSE UNEXPECTED 182 0.0041
486 RESPIRATORY RATE INCREASED 36 0.0041
487 DRUG USE DISORDER 34 0.0040
488 GENERALISED OEDEMA 50 0.0040
489 BACK PAIN 938 0.0040
490 MENTAL STATUS CHANGES 112 0.0040
491 RESPIRATORY TRACT CONGESTION 64 0.0040
492 RETINAL DETACHMENT 37 0.0040
493 THROMBOCYTOPENIA 450 0.0040
494 UPPER LIMB FRACTURE 80 0.0040
495 INTERVERTEBRAL DISC DEGENERATION 37 0.0040
496 SKIN CANCER 86 0.0040
497 RESPIRATORY TRACT INFECTION 104 0.0040
498 PLATELET COUNT INCREASED 52 0.0040
499 DRUG EFFECT LESS THAN EXPECTED 59 0.0040
500 PAROSMIA 30 0.0040
501 GLOSSODYNIA 89 0.0040
502 POST PROCEDURAL COMPLICATION 76 0.0040
503 DISEASE PROGRESSION 468 0.0040
504 HIP FRACTURE 127 0.0039
505 HUNGER 55 0.0039
506 BLOOD PRESSURE DECREASED 261 0.0039
507 BODY HEIGHT DECREASED 42 0.0039
508 HOT FLUSH 296 0.0039
509 UPPER RESPIRATORY TRACT INFECTION 181 0.0039
510 CONTUSION 376 0.0039
511 ILLNESS 402 0.0039
512 BLOOD URINE PRESENT 74 0.0039
513 VITAMIN D DEFICIENCY 38 0.0039
514 SCIATICA 62 0.0039
515 NASOPHARYNGITIS 714 0.0039
516 BODY TEMPERATURE INCREASED 79 0.0039
517 APHONIA 54 0.0039
518 APPENDICITIS 36 0.0039
519 BLOOD LACTATE DEHYDROGENASE INCREASED 61 0.0038
520 VIRAL INFECTION 128 0.0038
521 PLASMA CELL MYELOMA 150 0.0038
522 RESPIRATORY DEPRESSION 47 0.0038
523 ULCER 61 0.0038
524 PHOTOPHOBIA 72 0.0038
525 LIVER FUNCTION TEST ABNORMAL 111 0.0038
526 PYELONEPHRITIS 33 0.0038
527 LUNG INFECTION 59 0.0038
528 INTERNATIONAL NORMALISED RATIO INCREASED 108 0.0038
529 SINUSITIS 386 0.0038
530 HEPATOMEGALY 37 0.0038
531 VENTRICULAR EXTRASYSTOLES 39 0.0038
532 RASH PRURITIC 203 0.0037
533 ORTHOSTATIC HYPOTENSION 65 0.0037
534 HYPERSOMNIA 107 0.0037
535 OFF LABEL USE 3260 0.0037
536 SLEEP DISORDER 262 0.0037
537 CATARACT 221 0.0037
538 CHOLESTASIS 71 0.0037
539 INFLUENZA 412 0.0037
540 PULMONARY MASS 55 0.0037
541 BONE PAIN 215 0.0037
542 PAIN IN EXTREMITY 1081 0.0037
543 EMPHYSEMA 37 0.0037
544 ENCEPHALOPATHY 90 0.0037
545 HYPERTHYROIDISM 53 0.0037
546 HYPERAESTHESIA 30 0.0036
547 PULMONARY EMBOLISM 347 0.0036
548 RASH MACULO-PAPULAR 81 0.0036
549 LETHARGY 209 0.0036
550 DYSPNOEA 2051 0.0036
551 POLLAKIURIA 151 0.0036
552 LIMB INJURY 98 0.0036
553 PALLOR 98 0.0036
554 CARDIAC ARREST 297 0.0036
555 METASTASES TO BONE 59 0.0036
556 PANCREATITIS 190 0.0036
557 SECRETION DISCHARGE 45 0.0036
558 BRAIN NEOPLASM 33 0.0036
559 POLYNEUROPATHY 43 0.0036
560 HEART RATE IRREGULAR 81 0.0036
561 THYROID DISORDER 55 0.0036
562 PULMONARY CONGESTION 47 0.0036
563 HYPERKALAEMIA 125 0.0036
564 IMPAIRED HEALING 117 0.0036
565 IMPAIRED QUALITY OF LIFE 51 0.0035
566 VERTIGO 216 0.0035
567 SKIN DISORDER 118 0.0035
568 BLOOD CALCIUM INCREASED 31 0.0035
569 MITRAL VALVE INCOMPETENCE 40 0.0035
570 LUNG NEOPLASM MALIGNANT 145 0.0035
571 DIZZINESS 1759 0.0035
572 DENTAL CARIES 39 0.0035
573 LEUKOPENIA 176 0.0035
574 LOWER RESPIRATORY TRACT INFECTION 159 0.0035
575 NECK PAIN 195 0.0035
576 STAPHYLOCOCCAL INFECTION 115 0.0035
577 HYPERTENSION 738 0.0035
578 CHEST PAIN 645 0.0035
579 NEOPLASM PROGRESSION 121 0.0035
580 RENAL FAILURE 462 0.0035
581 ACCIDENTAL OVERDOSE 127 0.0035
582 GENERAL PHYSICAL HEALTH DETERIORATION 401 0.0035
583 MOVEMENT DISORDER 111 0.0035
584 JAUNDICE 93 0.0035
585 WRONG TECHNIQUE IN DRUG USAGE PROCESS 125 0.0034
586 HAIR TEXTURE ABNORMAL 46 0.0034
587 CANDIDA INFECTION 58 0.0034
588 DRY SKIN 457 0.0034
589 DEVICE OCCLUSION 48 0.0034
590 URINARY INCONTINENCE 101 0.0034
591 JOINT SWELLING 411 0.0034
592 TEMPERATURE INTOLERANCE 35 0.0034
593 LOCALISED INFECTION 82 0.0034
594 MALAISE 1487 0.0034
595 FALL 1128 0.0034
596 METABOLIC ACIDOSIS 108 0.0034
597 GASTROINTESTINAL HAEMORRHAGE 282 0.0034
598 BLOOD THYROID STIMULATING HORMONE INCREASED 31 0.0034
599 TACHYCARDIA 299 0.0034
600 TOOTH FRACTURE 37 0.0034
601 INCREASED APPETITE 64 0.0033
602 HYPERLIPIDAEMIA 40 0.0033
603 SNEEZING 75 0.0033
604 INFECTION 483 0.0033
605 DECREASED ACTIVITY 36 0.0033
606 HAEMOPTYSIS 93 0.0033
607 SLUGGISHNESS 34 0.0033
608 UPPER GASTROINTESTINAL HAEMORRHAGE 56 0.0033
609 HEPATIC ENCEPHALOPATHY 31 0.0033
610 OROPHARYNGEAL DISCOMFORT 30 0.0033
611 TOOTHACHE 60 0.0033
612 KIDNEY INFECTION 65 0.0033
613 HEADACHE 2076 0.0033
614 SUDDEN DEATH 35 0.0033
615 LIVER FUNCTION TEST INCREASED 71 0.0033
616 COVID-19 PNEUMONIA 39 0.0033
617 IMPAIRED GASTRIC EMPTYING 45 0.0033
618 RENAL IMPAIRMENT 277 0.0033
619 PNEUMOCYSTIS JIROVECII PNEUMONIA 33 0.0033
620 THROMBOSIS 264 0.0033
621 PRODUCT USE ISSUE 616 0.0033
622 JOINT INJURY 70 0.0033
623 LYMPHOPENIA 46 0.0032
624 ALANINE AMINOTRANSFERASE INCREASED 199 0.0032
625 HYPERCALCAEMIA 40 0.0032
626 MULTI-ORGAN FAILURE 56 0.0032
627 HERPES ZOSTER 186 0.0032
628 CONFUSIONAL STATE 521 0.0032
629 DEEP VEIN THROMBOSIS 209 0.0032
630 JOINT DISLOCATION 34 0.0032
631 HEART RATE INCREASED 318 0.0032
632 PHOTOSENSITIVITY REACTION 53 0.0032
633 RENAL DISORDER 149 0.0032
634 LACERATION 30 0.0032
635 OVERDOSE 687 0.0032
636 WOUND 89 0.0032
637 BALANCE DISORDER 275 0.0032
638 FUNGAL INFECTION 106 0.0032
639 ARTHRALGIA 1319 0.0032
640 COMPLICATION ASSOCIATED WITH DEVICE 46 0.0032
641 HAEMATEMESIS 80 0.0032
642 HEPATIC FAILURE 95 0.0031
643 NODULE 41 0.0031
644 DRUG LEVEL INCREASED 52 0.0031
645 RESPIRATORY FAILURE 229 0.0031
646 SKIN DISCOLOURATION 144 0.0031
647 CONJUNCTIVITIS 58 0.0031
648 NEUTROPHIL COUNT INCREASED 32 0.0031
649 DRUG INEFFECTIVE 4117 0.0031
650 HYPOAESTHESIA ORAL 47 0.0031
651 PULMONARY OEDEMA 139 0.0031
652 SINUS BRADYCARDIA 30 0.0031
653 PROTEINURIA 59 0.0031
654 FLUID OVERLOAD 45 0.0031
655 RASH MACULAR 108 0.0031
656 IMMUNODEFICIENCY 46 0.0031
657 AUTOIMMUNE DISORDER 30 0.0031
658 INTERSTITIAL LUNG DISEASE 149 0.0031
659 PRODUCT DOSE OMISSION IN ERROR 87 0.0031
660 CYTOMEGALOVIRUS INFECTION 51 0.0031
661 ARTHRITIS 241 0.0031
662 COAGULOPATHY 51 0.0031
663 PERIPHERAL COLDNESS 42 0.0031
664 DISORIENTATION 121 0.0031
665 TRANSIENT ISCHAEMIC ATTACK 103 0.0030
666 CYANOSIS 48 0.0030
667 FOLLICULITIS 32 0.0030
668 CHEST DISCOMFORT 312 0.0030
669 HYPOAESTHESIA 456 0.0030
670 FLUSHING 309 0.0030
671 RESTLESS LEGS SYNDROME 55 0.0030
672 PRODUCT PHYSICAL ISSUE 61 0.0030
673 GENERALISED TONIC-CLONIC SEIZURE 50 0.0030
674 LUNG DISORDER 148 0.0030
675 WEIGHT INCREASED 676 0.0030
676 MUSCULAR WEAKNESS 342 0.0030
677 INSURANCE ISSUE 46 0.0030
678 INSOMNIA 799 0.0030
679 SLEEP APNOEA SYNDROME 57 0.0030
680 QUALITY OF LIFE DECREASED 40 0.0030
681 HEPATIC CIRRHOSIS 56 0.0030
682 GASTRIC DISORDER 102 0.0030
683 GLYCOSYLATED HAEMOGLOBIN INCREASED 75 0.0030
684 EPILEPSY 90 0.0029
685 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 141 0.0029
686 BRAIN OEDEMA 37 0.0029
687 EAR DISCOMFORT 30 0.0029
688 EYE INFECTION 33 0.0029
689 POST PROCEDURAL HAEMORRHAGE 34 0.0029
690 LOSS OF CONSCIOUSNESS 374 0.0029
691 COVID-19 512 0.0029
692 ISCHAEMIC STROKE 52 0.0029
693 DRUG INTOLERANCE 281 0.0029
694 BREAST PAIN 31 0.0029
695 HAEMATURIA 99 0.0029
696 CONDITION AGGRAVATED 878 0.0029
697 SINUS TACHYCARDIA 41 0.0029
698 IMMUNE SYSTEM DISORDER 38 0.0029
699 LACRIMATION INCREASED 87 0.0029
700 UVEITIS 39 0.0029
701 ALOPECIA 564 0.0029
702 CYTOPENIA 35 0.0029
703 GLAUCOMA 55 0.0029
704 BLOOD TRIGLYCERIDES INCREASED 50 0.0028
705 SHOCK 65 0.0028
706 PRODUCT ADMINISTRATION ERROR 57 0.0028
707 OSTEOPOROSIS 116 0.0028
708 RASH 1229 0.0028
709 DEPRESSED MOOD 149 0.0028
710 HEPATIC FUNCTION ABNORMAL 105 0.0028
711 MICTURITION URGENCY 32 0.0028
712 CHOLECYSTECTOMY 32 0.0028
713 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 48 0.0028
714 TACHYPNOEA 38 0.0028
715 INTENTIONAL OVERDOSE 179 0.0028
716 RESPIRATORY DISTRESS 77 0.0028
717 GAIT DISTURBANCE 532 0.0028
718 HEAD DISCOMFORT 49 0.0028
719 ARRHYTHMIA 131 0.0028
720 PRODUCT USE IN UNAPPROVED INDICATION 681 0.0027
721 HEPATIC CYTOLYSIS 35 0.0027
722 STEVENS-JOHNSON SYNDROME 61 0.0027
723 BURNING SENSATION 192 0.0027
724 BLOOD GLUCOSE FLUCTUATION 30 0.0027
725 PAIN 1678 0.0027
726 MYALGIA 463 0.0027
727 CARDIOGENIC SHOCK 39 0.0027
728 MUSCLE TIGHTNESS 44 0.0027
729 NEURALGIA 66 0.0027
730 CARPAL TUNNEL SYNDROME 38 0.0027
731 DISCOMFORT 165 0.0027
732 PERITONITIS 56 0.0027
733 EYE HAEMORRHAGE 36 0.0027
734 ATAXIA 32 0.0027
735 BRADYCARDIA 143 0.0027
736 FOOT FRACTURE 51 0.0027
737 SCAR 46 0.0027
738 CHRONIC KIDNEY DISEASE 204 0.0027
739 THINKING ABNORMAL 50 0.0027
740 APHASIA 81 0.0027
741 BEDRIDDEN 35 0.0027
742 LIVER DISORDER 118 0.0027
743 PULMONARY FIBROSIS 51 0.0027
744 ANGINA PECTORIS 76 0.0026
745 NERVOUSNESS 138 0.0026
746 SWELLING 247 0.0026
747 DRUG INTERACTION 418 0.0026
748 HEAD INJURY 83 0.0026
749 HEPATITIS 67 0.0026
750 MOBILITY DECREASED 188 0.0026
751 FEELING ABNORMAL 627 0.0026
752 DRUG ADMINISTRATION ERROR 80 0.0026
753 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
754 ERYTHEMA 534 0.0026
755 ECONOMIC PROBLEM 39 0.0026
756 MYDRIASIS 33 0.0026
757 ROTATOR CUFF SYNDROME 33 0.0026
758 ORAL HERPES 50 0.0026
759 PRODUCT PRESCRIBING ERROR 61 0.0026
760 INFLAMMATION 132 0.0026
761 EAR INFECTION 68 0.0026
762 ARTHROPATHY 142 0.0026
763 FIBROMYALGIA 62 0.0025
764 SPINAL FRACTURE 51 0.0025
765 DELIRIUM 88 0.0025
766 RASH ERYTHEMATOUS 121 0.0025
767 MUSCLE ATROPHY 32 0.0025
768 MUSCULOSKELETAL PAIN 132 0.0025
769 PARAESTHESIA 396 0.0025
770 PALPITATIONS 294 0.0025
771 COORDINATION ABNORMAL 35 0.0025
772 DYSSTASIA 73 0.0025
773 SARS-COV-2 TEST POSITIVE 33 0.0025
774 DRUG PRESCRIBING ERROR 48 0.0025
775 DYSARTHRIA 94 0.0025
776 DEVICE FAILURE 38 0.0025
777 FACE OEDEMA 42 0.0025
778 MEMORY IMPAIRMENT 342 0.0025
779 MYELODYSPLASTIC SYNDROME 36 0.0025
780 TREMOR 412 0.0025
781 CARDIAC FAILURE 199 0.0025
782 MALIGNANT MELANOMA 33 0.0025
783 PRODUCT DOSE OMISSION ISSUE 724 0.0025
784 MIGRAINE 235 0.0025
785 RASH PAPULAR 55 0.0025
786 MUSCULOSKELETAL STIFFNESS 214 0.0024
787 CYTOKINE RELEASE SYNDROME 49 0.0024
788 CARDIOMYOPATHY 36 0.0024
789 PRESCRIBED OVERDOSE 47 0.0024
790 CARDIAC FAILURE CONGESTIVE 195 0.0024
791 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 133 0.0024
792 UNRESPONSIVE TO STIMULI 62 0.0024
793 HEPATOCELLULAR INJURY 34 0.0024
794 AGRANULOCYTOSIS 44 0.0024
795 SWELLING FACE 154 0.0024
796 BONE MARROW FAILURE 48 0.0024
797 PRESCRIBED UNDERDOSE 47 0.0024
798 HAEMATOMA 61 0.0024
799 FEELING HOT 144 0.0023
800 SKIN REACTION 33 0.0023
801 ADVERSE REACTION 31 0.0023
802 CARDIAC DISORDER 218 0.0023
803 SKIN EXFOLIATION 196 0.0023
804 MENTAL DISORDER 101 0.0023
805 DIPLOPIA 60 0.0023
806 HYPERHIDROSIS 297 0.0023
807 HEMIPARESIS 39 0.0023
808 DEMENTIA 64 0.0023
809 CONTRAINDICATED PRODUCT ADMINISTERED 69 0.0023
810 OSTEONECROSIS OF JAW 56 0.0023
811 ANXIETY 643 0.0023
812 PRURITUS 865 0.0022
813 BONE DISORDER 41 0.0022
814 VISUAL IMPAIRMENT 278 0.0022
815 HYPERSENSITIVITY 416 0.0022
816 TOXICITY TO VARIOUS AGENTS 377 0.0022
817 DEPRESSION 505 0.0022
818 DIABETES MELLITUS 169 0.0022
819 AMNESIA 144 0.0022
820 DIABETES MELLITUS INADEQUATE CONTROL 39 0.0022
821 DERMATITIS 46 0.0022
822 DRUG EFFECT DECREASED 118 0.0022
823 CORONARY ARTERY OCCLUSION 30 0.0022
824 LOCAL SWELLING 38 0.0022
825 ROAD TRAFFIC ACCIDENT 91 0.0022
826 RESPIRATORY DISORDER 65 0.0022
827 ACUTE MYOCARDIAL INFARCTION 64 0.0022
828 UNEVALUABLE EVENT 164 0.0022
829 SUBDURAL HAEMATOMA 31 0.0022
830 SKIN HAEMORRHAGE 32 0.0022
831 VISION BLURRED 294 0.0021
832 HAEMORRHAGE 223 0.0021
833 INFLUENZA LIKE ILLNESS 175 0.0021
834 NERVOUS SYSTEM DISORDER 66 0.0021
835 INTENTIONAL DOSE OMISSION 60 0.0021
836 ADVERSE DRUG REACTION 189 0.0021
837 COLD SWEAT 37 0.0021
838 FEELING JITTERY 40 0.0021
839 TINNITUS 96 0.0021
840 PANIC ATTACK 76 0.0021
841 SWOLLEN TONGUE 65 0.0021
842 PAIN OF SKIN 56 0.0021
843 ALTERED STATE OF CONSCIOUSNESS 45 0.0021
844 ACTIVITIES OF DAILY LIVING IMPAIRED 41 0.0021
845 BLOOD GLUCOSE DECREASED 99 0.0021
846 CARDIO-RESPIRATORY ARREST 86 0.0021
847 ANHEDONIA 54 0.0021
848 THERAPEUTIC PRODUCT EFFECT DECREASED 92 0.0021
849 THERAPEUTIC RESPONSE DECREASED 124 0.0020
850 SPEECH DISORDER 107 0.0020
851 MIDDLE INSOMNIA 38 0.0020
852 COGNITIVE DISORDER 95 0.0020
853 TREATMENT NONCOMPLIANCE 111 0.0020
854 TRANSAMINASES INCREASED 45 0.0020
855 HYPOGLYCAEMIA 98 0.0020
856 ANKLE FRACTURE 31 0.0020
857 TENDONITIS 31 0.0020
858 MELAENA 44 0.0020
859 HOSPITALISATION 307 0.0020
860 EOSINOPHILIA 35 0.0020
861 SEIZURE 230 0.0020
862 DEAFNESS 52 0.0020
863 RENAL INJURY 59 0.0020
864 JOINT STIFFNESS 52 0.0020
865 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56 0.0020
866 PRODUCT AVAILABILITY ISSUE 45 0.0020
867 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 396 0.0020
868 HYPOACUSIS 84 0.0019
869 EYE DISORDER 64 0.0019
870 DEPRESSED LEVEL OF CONSCIOUSNESS 77 0.0019
871 CIRCULATORY COLLAPSE 33 0.0019
872 ACUTE MYELOID LEUKAEMIA 30 0.0019
873 HALLUCINATION 143 0.0019
874 URTICARIA 317 0.0019
875 CEREBROVASCULAR ACCIDENT 317 0.0019
876 ADVERSE EVENT 171 0.0019
877 DISTURBANCE IN ATTENTION 100 0.0019
878 ANAPHYLACTIC REACTION 102 0.0018
879 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31 0.0018
880 ACUTE RESPIRATORY DISTRESS SYNDROME 32 0.0018
881 PRODUCT DOSE OMISSION 116 0.0018
882 RESTLESSNESS 65 0.0018
883 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 52 0.0018
884 MENTAL IMPAIRMENT 43 0.0018
885 SURGERY 104 0.0018
886 EYE PAIN 100 0.0018
887 ACNE 134 0.0018
888 SUICIDE ATTEMPT 107 0.0018
889 LIVER INJURY 43 0.0018
890 BLOOD GLUCOSE INCREASED 327 0.0017
891 ASTHMA 195 0.0017
892 MOOD ALTERED 47 0.0017
893 BLOOD CHOLESTEROL INCREASED 80 0.0017
894 WITHDRAWAL SYNDROME 72 0.0017
895 PELVIC PAIN 31 0.0017
896 LIP SWELLING 56 0.0017
897 DRUG EFFECT INCOMPLETE 61 0.0017
898 GAIT INABILITY 56 0.0017
899 RESPIRATORY ARREST 46 0.0017
900 NEOPLASM MALIGNANT 111 0.0017
901 AGITATION 122 0.0017
902 RASH GENERALISED 43 0.0017
903 CORONARY ARTERY DISEASE 50 0.0016
904 ANAPHYLACTIC SHOCK 42 0.0016
905 ANGER 55 0.0016
906 DYSKINESIA 66 0.0016
907 ABASIA 40 0.0016
908 INJURY 113 0.0016
909 EYE PRURITUS 54 0.0016
910 IMPAIRED WORK ABILITY 34 0.0016
911 FRACTURE 30 0.0016
912 LACTIC ACIDOSIS 51 0.0016
913 TYPE 2 DIABETES MELLITUS 53 0.0016
914 DEATH 1352 0.0016
915 PRODUCT PRESCRIBING ISSUE 34 0.0016
916 THROAT TIGHTNESS 42 0.0016
917 ABNORMAL BEHAVIOUR 61 0.0015
918 EYE SWELLING 57 0.0015
919 ILL-DEFINED DISORDER 92 0.0015
920 TOOTH LOSS 31 0.0015
921 RHEUMATOID ARTHRITIS 169 0.0015
922 RHABDOMYOLYSIS 62 0.0015
923 TREATMENT FAILURE 122 0.0015
924 ECZEMA 77 0.0015
925 IRRITABILITY 88 0.0015
926 DIABETIC KETOACIDOSIS 35 0.0015
927 INTENTIONAL DRUG MISUSE 30 0.0014
928 EXTRA DOSE ADMINISTERED 58 0.0014
929 THERAPEUTIC RESPONSE SHORTENED 47 0.0014
930 THERAPY INTERRUPTED 101 0.0014
931 NEEDLE ISSUE 41 0.0014
932 MEDICATION ERROR 78 0.0014
933 MYOCARDIAL INFARCTION 244 0.0014
934 EMOTIONAL DISORDER 43 0.0014
935 MUSCLE TWITCHING 32 0.0014
936 CEREBRAL HAEMORRHAGE 48 0.0013
937 DEVICE DISLOCATION 58 0.0013
938 FEMUR FRACTURE 41 0.0013
939 DRUG-INDUCED LIVER INJURY 41 0.0013
940 AGGRESSION 65 0.0013
941 CRYING 47 0.0013
942 THERAPY CESSATION 62 0.0012
943 INJECTION SITE PAIN 367 0.0012
944 EXPOSURE DURING PREGNANCY 74 0.0012
945 OSTEONECROSIS 39 0.0012
946 OCULAR HYPERAEMIA 56 0.0012
947 INJECTION SITE BRUISING 93 0.0012
948 ABORTION SPONTANEOUS 46 0.0011
949 BLOOD CREATINE PHOSPHOKINASE INCREASED 33 0.0011
950 PANCREATIC CARCINOMA 33 0.0011
951 DEVICE ISSUE 102 0.0011
952 DRUG DOSE OMISSION 188 0.0011
953 SKIN IRRITATION 52 0.0011
954 NIGHTMARE 39 0.0011
955 FEAR 30 0.0011
956 MULTIPLE SCLEROSIS 52 0.0011
957 VISUAL ACUITY REDUCED 36 0.0011
958 BONE DENSITY DECREASED 33 0.0011
959 DISEASE RECURRENCE 49 0.0010
960 INJECTION SITE ERYTHEMA 127 0.0010
961 INJECTION SITE RASH 31 0.0010
962 BLINDNESS 41 0.0010
963 DEVICE LEAKAGE 43 0.0010
964 EYE IRRITATION 56 0.0010
965 ANGIOEDEMA 43 0.0010
966 INJECTION SITE PRURITUS 65 0.0010
967 INJECTION SITE HAEMORRHAGE 77 0.0010
968 MOOD SWINGS 30 0.0009
969 DEVICE MALFUNCTION 66 0.0009
970 SUICIDAL IDEATION 85 0.0009
971 DRUG WITHDRAWAL SYNDROME 81 0.0009
972 DEVICE USE ERROR 32 0.0009
973 CONVULSION 52 0.0009
974 EMOTIONAL DISTRESS 109 0.0009
975 PRODUCT QUALITY ISSUE 114 0.0008
976 DRUG DEPENDENCE 134 0.0008
977 INJECTION SITE REACTION 56 0.0008
978 INJECTION SITE MASS 30 0.0008
979 VAGINAL HAEMORRHAGE 35 0.0008
980 PSORIASIS 102 0.0008
981 MULTIPLE SCLEROSIS RELAPSE 53 0.0008
982 INJECTION SITE SWELLING 58 0.0008
983 BREAST CANCER 62 0.0007
984 PRODUCT STORAGE ERROR 57 0.0007
985 PRODUCT SUBSTITUTION ISSUE 37 0.0006
986 NO ADVERSE EVENT 104 0.0006
987 ACCIDENTAL EXPOSURE TO PRODUCT 58 0.0006
988 PROSTATE CANCER 45 0.0006
989 SKIN BURNING SENSATION 38 0.0005
990 COMPLETED SUICIDE 37 0.0004
991 FOETAL EXPOSURE DURING PREGNANCY 36 0.0004
992 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004